Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-16
2008-09-16
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S282700
Reexamination Certificate
active
10482396
ABSTRACT:
Therapeutically active compounds of formula (I):wherein the variables shown in formula (I) are defined in the disclosure; and pharmaceutically acceptable salts and esters thereof. The compounds are potent inhibitors of the Na+/Ca2+exchange mechanism.
REFERENCES:
patent: 2820817 (1958-01-01), Sam
patent: 3862232 (1975-01-01), Lednicer
patent: 5703118 (1997-12-01), Durand et al.
patent: 6177449 (2001-01-01), Brendel et al.
patent: 2006/0241147 (2006-10-01), Otsomaa et al.
patent: 0 978 506 (2000-02-01), None
patent: 1 031 556 (2000-08-01), None
patent: 1068751 (1967-05-01), None
patent: 1154119 (1969-06-01), None
patent: 9-67336 (1997-03-01), None
patent: 09067336 (1997-03-01), None
patent: 11049752 (1999-02-01), None
patent: 11302235 (1999-11-01), None
patent: WO 00/64445 (2000-11-01), None
patent: WO 01/21610 (2001-03-01), None
Spido et al., “Sodium Calcium Exchange as a Target, etc.,”, Handbook of Experimental Pharmacology, NY: Springer-Verlag, 2006 (171) 159-199.
Noble, “Simulation of Na/Ca Exchange, etc.,” Ann. N.Y. Acad. Sci. 976:431-437 (2002).
Sipido et al. “Altered Na/Ca exchange activity, etc.,” Cardiovascular Research 53 (2002) 782-805.
Patent Abstracts of Japan, vol. 200, No. 2, Feb. 29, 2000 and JP 11 302235 A (Taisho Pharmaceut Co LTD), Nov. 2, 1999 (Abstract).
Patent Abstracts of Japan, vol. 199, No. 905, May 31, 1999 & JP 11 049752 A (Taisho Pharmaceut Co LTD), Feb. 23, 1999 (Abstract).
Database WPI: Week 199718, Derwent Publications Ltd., JP 9067336.
Karjalainen Arto
Koskelainen Tuula
Kotovuori Pekka
Nore Pentti
Otsomaa Leena
Finnegan Henderson Farabow Garrett & Dunner LLP
Morris Patricia L
Orion Corporation
LandOfFree
Compounds, which are potent inhibitors of Na + /Ca 2+... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, which are potent inhibitors of Na + /Ca 2+..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, which are potent inhibitors of Na + /Ca 2+... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3924956